Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer.
Zazo S, González-Alonso P, Martín-Aparicio E, Chamizo C, Luque M, Sanz-Álvarez M, Mínguez P, Gómez-López G, Cristóbal I, Caramés C, García-Foncillas J, Eroles P, Lluch A, Arpí O, Rovira A, Albanell J, Madoz-Gúrpide J, Rojo F.
Zazo S, et al.
Mol Cancer Ther. 2020 Aug;19(8):1696-1707. doi: 10.1158/1535-7163.MCT-19-1172. Epub 2020 May 13.
Mol Cancer Ther. 2020.
PMID: 32404410